 
1 
 
Extension of the MDR Transitional Period and Removal of 
the “Sell Off” Periods - Q&A on Practical Aspects Related 
to the Implementation of Regulation (EU) 2023/607, Mar-
2023 
The following document of the European Commission provides the Q&A document that is intended to facilitate the 
application of the "Regulation (EU) 2023/607 of the European Parliament and of the Council Amending Regulations (EU) 
2017/745 and (EU) 2017/746 as regards the Transitional Provisions for Certain Medical Devices and In Vitro Diagnostic 
Medical Devices, 15-Mar-2023".  
This document has not been formally endorsed by the European Commission and is without prejudice to any 
interpretation of the relevant provisions by the Court of Justice of the European Union or national courts. The 
information in this Q&A document is of a general nature and not intended to address specific circumstances of any 
particular case; the document does not intend to provide professional or legal advice. The information is not necessarily 
comprehensive nor complete. If needed, this document will be updated in order to address additional questions that 
may arise. 
